CEGEDIM SA (ALCGM.PA) Stock Fundamental Analysis

EPA:ALCGM • FR0000053506

13 EUR
+0.2 (+1.56%)
Last: Feb 13, 2026, 07:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALCGM. ALCGM was compared to 11 industry peers in the Health Care Technology industry. ALCGM has a bad profitability rating. Also its financial health evaluation is rather negative. ALCGM is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • ALCGM had negative earnings in the past year.
  • In the past year ALCGM had a positive cash flow from operations.
  • In multiple years ALCGM reported negative net income over the last 5 years.
  • In the past 5 years ALCGM always reported a positive cash flow from operatings.
ALCGM.PA Yearly Net Income VS EBIT VS OCF VS FCFALCGM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • ALCGM has a Return On Assets (-1.40%) which is in line with its industry peers.
  • With a Return On Equity value of -5.21%, ALCGM perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
  • ALCGM has a better Return On Invested Capital (5.28%) than 63.64% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALCGM is significantly below the industry average of 8.41%.
  • The last Return On Invested Capital (5.28%) for ALCGM is above the 3 year average (2.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.4%
ROE -5.21%
ROIC 5.28%
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
ALCGM.PA Yearly ROA, ROE, ROICALCGM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • With a Operating Margin value of 6.78%, ALCGM perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ALCGM has declined.
  • Looking at the Gross Margin, with a value of 20.65%, ALCGM is doing worse than 81.82% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALCGM has declined.
Industry RankSector Rank
OM 6.78%
PM (TTM) N/A
GM 20.65%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
ALCGM.PA Yearly Profit, Operating, Gross MarginsALCGM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALCGM is destroying value.
  • The number of shares outstanding for ALCGM has been increased compared to 1 year ago.
  • The number of shares outstanding for ALCGM has been reduced compared to 5 years ago.
  • ALCGM has a worse debt/assets ratio than last year.
ALCGM.PA Yearly Shares OutstandingALCGM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALCGM.PA Yearly Total Debt VS Total AssetsALCGM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • ALCGM has an Altman-Z score of 1.30. This is a bad value and indicates that ALCGM is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of ALCGM (1.30) is comparable to the rest of the industry.
  • ALCGM has a debt to FCF ratio of 5.84. This is a neutral value as ALCGM would need 5.84 years to pay back of all of its debts.
  • ALCGM's Debt to FCF ratio of 5.84 is in line compared to the rest of the industry. ALCGM outperforms 54.55% of its industry peers.
  • ALCGM has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of ALCGM (1.11) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.84
Altman-Z 1.3
ROIC/WACC0.98
WACC5.36%
ALCGM.PA Yearly LT Debt VS Equity VS FCFALCGM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.93 indicates that ALCGM may have some problems paying its short term obligations.
  • The Current ratio of ALCGM (0.93) is worse than 63.64% of its industry peers.
  • A Quick Ratio of 0.91 indicates that ALCGM may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.91, ALCGM is doing worse than 63.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.91
ALCGM.PA Yearly Current Assets VS Current LiabilitesALCGM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

  • The earnings per share for ALCGM have decreased strongly by -763.97% in the last year.
  • Looking at the last year, ALCGM shows a small growth in Revenue. The Revenue has grown by 3.79% in the last year.
  • The Revenue has been growing slightly by 5.38% on average over the past years.
EPS 1Y (TTM)-763.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.96%
Revenue 1Y (TTM)3.79%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%1.1%

3.2 Future

  • ALCGM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.06% yearly.
  • Based on estimates for the next years, ALCGM will show a small growth in Revenue. The Revenue will grow by 3.41% on average per year.
EPS Next Y0%
EPS Next 2Y19.73%
EPS Next 3Y22.06%
EPS Next 5YN/A
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALCGM.PA Yearly Revenue VS EstimatesALCGM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
ALCGM.PA Yearly EPS VS EstimatesALCGM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALCGM. In the last year negative earnings were reported.
  • ALCGM is valuated cheaply with a Price/Forward Earnings ratio of 7.79.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALCGM indicates a rather cheap valuation: ALCGM is cheaper than 100.00% of the companies listed in the same industry.
  • ALCGM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.96.
Industry RankSector Rank
PE N/A
Fwd PE 7.79
ALCGM.PA Price Earnings VS Forward Price EarningsALCGM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALCGM is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • 100.00% of the companies in the same industry are more expensive than ALCGM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.33
EV/EBITDA 3.12
ALCGM.PA Per share dataALCGM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALCGM's earnings are expected to grow with 22.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.73%
EPS Next 3Y22.06%

0

5. Dividend

5.1 Amount

  • No dividends for ALCGM!.
Industry RankSector Rank
Dividend Yield 0%

CEGEDIM SA

EPA:ALCGM (2/13/2026, 7:00:00 PM)

13

+0.2 (+1.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners14.55%
Inst Owner ChangeN/A
Ins Owners57.78%
Ins Owner ChangeN/A
Market Cap183.30M
Revenue(TTM)658.00M
Net Income(TTM)-13.82M
Analysts44.44
Price Target12.92 (-0.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.5%
EPS NY rev (3m)1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.79
P/S 0.28
P/FCF 3.33
P/OCF 1.34
P/B 0.69
P/tB N/A
EV/EBITDA 3.12
EPS(TTM)-0.98
EYN/A
EPS(NY)1.67
Fwd EY12.84%
FCF(TTM)3.9
FCFY29.99%
OCF(TTM)9.69
OCFY74.53%
SpS46.67
BVpS18.8
TBVpS-11.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.4%
ROE -5.21%
ROCE 7.18%
ROIC 5.28%
ROICexc 5.74%
ROICexgc 22.49%
OM 6.78%
PM (TTM) N/A
GM 20.65%
FCFM 8.35%
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
ROICexc(3y)3.13%
ROICexc(5y)4.15%
ROICexgc(3y)11.62%
ROICexgc(5y)15.26%
ROCE(3y)3.91%
ROCE(5y)5.29%
ROICexgc growth 3Y0.21%
ROICexgc growth 5Y-3.19%
ROICexc growth 3Y-3.24%
ROICexc growth 5Y-2.52%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.84
Debt/EBITDA 2.02
Cap/Depr 80.74%
Cap/Sales 12.41%
Interest Coverage 3.25
Cash Conversion 93.73%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.91
Altman-Z 1.3
F-Score5
WACC5.36%
ROIC/WACC0.98
Cap/Depr(3y)92.57%
Cap/Depr(5y)94.88%
Cap/Sales(3y)13.24%
Cap/Sales(5y)13.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-763.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.96%
EPS Next Y0%
EPS Next 2Y19.73%
EPS Next 3Y22.06%
EPS Next 5YN/A
Revenue 1Y (TTM)3.79%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%1.1%
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A
EBIT growth 1Y122.96%
EBIT growth 3Y0.5%
EBIT growth 5Y1.66%
EBIT Next Year283.35%
EBIT Next 3Y64.54%
EBIT Next 5YN/A
FCF growth 1Y89.23%
FCF growth 3Y-27.43%
FCF growth 5YN/A
OCF growth 1Y24.18%
OCF growth 3Y2%
OCF growth 5Y28.33%

CEGEDIM SA / ALCGM.PA FAQ

What is the ChartMill fundamental rating of CEGEDIM SA (ALCGM.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALCGM.PA.


What is the valuation status for ALCGM stock?

ChartMill assigns a valuation rating of 5 / 10 to CEGEDIM SA (ALCGM.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for CEGEDIM SA?

CEGEDIM SA (ALCGM.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for ALCGM stock?

The financial health rating of CEGEDIM SA (ALCGM.PA) is 2 / 10.


Can you provide the dividend sustainability for ALCGM stock?

The dividend rating of CEGEDIM SA (ALCGM.PA) is 0 / 10 and the dividend payout ratio is 0%.